Aspirin could help breast cancer patients reduce their risk of recurrence.
That's according to a new study led by researchers at the University of Texas in Austin and published in 'Cancer Research'
This protective effect was among obese and overweight women with hormone-related forms of breast cancer.
Data from more than 400 patients showed asprin users had a 52-percent lower rate of recurrence and a 28-month delay in time,, if they did have to fight a second bout of the disease.
Researchers say aspirin and other anti-inflammatory drugs help reduce inflammation in tumor cells and prevent them from growing and spreading.